Real-time enrollment status for this primary biliary cholangitis clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 10:20 PM UTC
| NCT Number | NCT06051617 |
| Recruiting Status | Recruiting |
| Condition | Primary Biliary Cholangitis |
| Phase | PHASE3 |
| Target Enrollment | 318 participants |
| Active Locations | 52 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | August 11, 2026 (3 weeks ago) |
As of September 1, 2026: Clinical trial NCT06051617 is currently recruiting participants. This phase3 study for primary biliary cholangitis is actively seeking new participants at 52 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06051617 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 52 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06051617 was last updated 3 weeks ago (August 11, 2026). HelloStudys verifies this status automatically.